share_log
Breakings ·  Jul 1 20:00
Ovid: Phase 2 Study for Treatment of Cerebral Cavernous Malformations Is Expected to Initiate in H2
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment